医療放射線遮蔽市場 : 2028年までの世界予測

Report Overview

The medical radiation shielding market is projected to reach USD 1.8 Billion by 2028 from USD 1.4 Billion in 2023, at a CAGR of 6.5% during the forecast period. Growth in MRI shielding products is mainly driven by the Awareness of the potential health risks associated with exposure to ionizing radiation is increasing rapidly among people working in radiation-prone environments. Various government and private organizations, such as Health Canada, the National Council on Radiation Protection & Measurements (NCRP), and the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), have incorporated guidelines and protocols regarding radiation shielding products. These initiatives increase safety awareness among professionals and encourage the adoption of radiation protection systems. Conferences and symposia also showcase research in this field and make industry leaders aware of the developments in this sector.

“The Diagnostic Shielding segment accounted for the highest market share in the medical radiation shielding solution market, by type, during the forecast period.”
Based on the solution of the segment, the medical radiation shielding market is categorized as Diagnostic Shielding and Radiation Therapy Shielding. Diagnostic Shielding is expected to have the highest growth in the market, which is attributed to the rising prevalence of various chronic diseases like cancer, which is attributed to the Increasing public-private investments in cancer research, id supporting the growth of the Diagnostic Shielding market.

“The North America segment accounted for the highest market share in the medical radiation shielding market, by region, during the forecast period.”
Based on the region, the global medical radiation shielding market is categorized into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to witness a high market share during the forecast period due to the Increasing number of trained radiologic technologists. According to the Bureau of Labor Statistics, in 2020, ~254,000 radiologic technologists’ jobs were expected to be available in the US. The Bureau of Labor Statistics has also estimated that the employment of radiologic and MRI technologists is expected to grow at a rate of 9% from 2020 to 2030 in the US.

Breakdown of supply-side primary interviews by company type, designation, and region:

• By Company Type: Tier 1 (32%), Tier 2 (46%), and Tier 3 (22%)
• By Designation: C-level (40%), Director-level (26%), and Others (34%)
• By Region: North America (35%), Europe (30%), Asia- Pacific (21%), RoW- (14%),
  Prominent companies include ESCO Technologies (US), Mirion Technology (US), Nelco Worldwide (US), Gaven Industries Inc. (US), Radiation Protection Products, Inc. (US), Marshield (Canada), Ray-Bar Engineering Corp. (US), Amray Medical (Ireland), A&L Shielding (US), Global Partners in Shielding Inc. (US), Veritas Medical Solutions LLC. (US), AliMed Inc. (US), Protech Medical (US), Ultraray (US), Mars Metal Company (Canada), Nuclear Lead Co. Inc. (US), Nuclear Shields B.V. (Netherlands), Globe Composite Solutions LLC. (US), Shielding International Inc. (US), Bar-Ray Products (US), Xena Shield (India), Burlington Medical (US), SIMAD S.r.l. (Italy) and European EMC Products (UK).
  Research Coverage
  This research report categorizes the medical radiation shielding market by product (MRI Shielding Products, Lead Lined Glass, Doors & Windows, Lead Lined Drywalls & Plywood, Shields, Barriers, Booths, Lead Sheet, Lead Bricks, High-Density Concrete Blocks, X-ray Rooms, Lead Curtains & Screens and Lead Acrylic), By Solution (Diagnostic Shielding and Radiation Therapy Shielding), Diagnostic Shielding segment (X-ray, MRI, CT scanners and Nuclear Imaging) and Radiation Therapy Shielding segment (Linear Accelerator, Multimodality, Cyclotron, Brachytherapy, and Proton Therapy), by end-user (Hospitals, Clinics and Ambulatory Surgery Centers and Diagnostic Centers), and region (North America, Europe, Asia Pacific and Rest of world). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the medical radiation shielding market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the medical radiation shielding market. Competitive analysis of upcoming startups in the medical radiation shielding market ecosystem is covered in this report.
  Key Benefits of Buying the Report:
  The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical radiation shielding market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
  The report provides insights on the following pointers:
  • Analysis of key drivers (Increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, Growing incidences of cancer, Increasing safety awareness among people working in radiation-prone environments, Growth in the number of PET/CT scans, and Increasing number of trained radiologic technologists,), restraints (Lack of adequate healthcare infrastructure and Dearth Of Skilled Oncologist/Radiologist) opportunities (Rising healthcare expenditure across developing countries, Increasing public-private investments in cancer research, Growing government and private investments to meet the increasing demand for cancer treatment, Technological advancements in radiation detection and Increasing usage of nuclear medicine & radiation therapy coupled with the rising incidence of cancer) and Challenges (High cost of lead in manufacturing radiation accessories) are influencing the growth of the radiation shielding market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical radiation shielding market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the medical radiation shielding market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical radiation shielding market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, among others, in the medical radiation shielding market strategies.

Table of Contents

1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS & EXCLUSIONS 25
1.3 MARKET SCOPE 26
1.3.1 MARKETS COVERED 26
FIGURE 1 MEDICAL RADIATION SHIELDING MARKET SEGMENTATION 26
1.3.2 GEOGRAPHIC SCOPE 26
1.3.3 YEARS CONSIDERED 27
1.4 CURRENCY 27
1.5 LIMITATIONS 27
1.6 MARKET STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 2 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Secondary sources 30
2.1.2 PRIMARY DATA 31
FIGURE 3 PRIMARY SOURCES 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Key industry insights 33
2.1.2.3 Breakdown of primary interviews 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS 34
2.2 MARKET SIZE ESTIMATION 34
2.2.1 GROWTH FORECAST 36
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 36
FIGURE 7 TOP-DOWN APPROACH 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38
FIGURE 8 DATA TRIANGULATION METHODOLOGY 38
2.4 MARKET SHARE ANALYSIS 39
2.5 ASSUMPTIONS 39
2.6 INDICATORS AND ASSUMPTIONS 40
2.7 RISK ASSESSMENT 40
TABLE 1 RISK ASSESSMENT 40
2.8 IMPACT OF RECESSION: MEDICAL RADIATION SHIELDING MARKET 41
3 EXECUTIVE SUMMARY 42
FIGURE 9 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 42
FIGURE 10 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2023 VS. 2028 (USD MILLION) 43
FIGURE 11 MEDICAL RADIATION SHIELDING MARKET FOR RADIATION THERAPY SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION) 44
FIGURE 12 MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION) 45
FIGURE 13 MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 46
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MEDICAL RADIATION SHIELDING MARKET 47
4 PREMIUM INSIGHTS 48
4.1 MEDICAL RADIATION SHIELDING MARKET OVERVIEW 48
FIGURE 15 GROWING GLOBAL INCIDENCE OF CANCER TO DRIVE MARKET GROWTH 48
4.2 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION AND COUNTRY, 2022 49
FIGURE 16 DIAGNOSTIC SHIELDING HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022 49
4.3 MEDICAL RADIATION SHIELDING MARKET: GEOGRAPHIC SNAPSHOT 50
FIGURE 17 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 18 MEDICAL RADIATION SHIELDING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
5.2.1 DRIVERS 52
5.2.1.1 Increasing use of nuclear medicine and radiation therapy for diagnosis and treatment 52
5.2.1.2 Growing incidence of cancer 52
TABLE 2 NUMBER OF NEW CANCER CASES, 2020–2040 53
TABLE 3 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION) 53
5.2.1.3 Increasing safety awareness among people working in radiation-prone environments 53
5.2.1.4 Growth in number of PET/CT scans 54
TABLE 4 CT SCANNERS INSTALLED, BY COUNTRY, 2019 VS. 2021 (PER MILLION INHABITANTS) 54
TABLE 5 CT SCAN PROCEDURAL VOLUME, BY COUNTRY, 2019 VS. 2021 (PER 1,000 INHABITANTS) 54
5.2.1.5 Increasing number of trained radiologic technologists 54
TABLE 6 METROPOLITAN AREAS IN US WITH HIGH EMPLOYMENT LEVELS AMONG RADIOLOGY TECHNOLOGISTS AND TECHNICIANS 55
5.2.2 RESTRAINTS 55
5.2.2.1 Lack of adequate healthcare infrastructure 55
5.2.2.2 Shortage of skilled oncologists/radiologists 55
5.2.3 OPPORTUNITIES 56
5.2.3.1 Rising healthcare expenditure across developing countries 56
5.2.3.2 Increasing public-private investments in cancer research 56
5.2.3.3 Technological advancements in radiation detection 57
5.2.4 CHALLENGES 57
5.2.4.1 High cost of lead in manufacturing radiation accessories 57
5.3 VALUE CHAIN ANALYSIS 58
FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 58
5.4 SUPPLY CHAIN ANALYSIS 59
FIGURE 20 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES 59
5.5 PORTER’S FIVE FORCES ANALYSIS 60
5.5.1 THREAT OF NEW ENTRANTS 60
5.5.2 THREAT OF SUBSTITUTES 60
5.5.3 BARGAINING POWER OF BUYERS 60
5.5.4 BARGAINING POWER OF SUPPLIERS 60
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.6 KEY STAKEHOLDERS & BUYING CRITERIA 61
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 61
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS 61
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%) 61
5.6.2 BUYING CRITERIA 62
FIGURE 22 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS 62
TABLE 8 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS 62
5.7 REGULATORY LANDSCAPE 63
5.7.1 NORTH AMERICA 63
5.7.2 EUROPE 64
5.7.3 ASIA PACIFIC 64
5.8 TRADE ANALYSIS 64
TABLE 9 IMPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND) 64
TABLE 10 EXPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND) 65
5.9 ECOSYSTEM ANALYSIS 65
FIGURE 23 KEY PLAYERS OPERATING IN MEDICAL RADIATION SHIELDING MARKET 65
TABLE 11 ROLE IN ECOSYSTEM 66
5.10 PATENT ANALYSIS 67
5.11 KEY CONFERENCES & EVENTS IN 2023–2024 68
TABLE 12 LIST OF CONFERENCES & EVENTS 68
5.12 PRICING ANALYSIS 69
5.12.1 AVERAGE SELLING PRICE OF KEY PRODUCTS 69
TABLE 13 PRICE RANGE OF KEY PRODUCTS IN MEDICAL RADIATION SHIELDING MARKET (USD) 69
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 70
5.14 TECHNOLOGY ANALYSIS 70
6 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT 72
6.1 INTRODUCTION 73
TABLE 14 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 73
6.2 MRI SHIELDING PRODUCTS 74
6.2.1 INCREASING INSTALLATION BASE OF MRI SCANNERS WORLDWIDE TO BOOST MARKET 74
TABLE 15 MEDICAL RADIATION SHIELDING MARKET FOR MRI SHIELDING PRODUCTS, BY REGION, 2021–2028 (USD MILLION) 74
6.3 LEAD-LINED GLASS, DOORS, AND WINDOWS 75
6.3.1 ABILITY OF LEAD-LINED GLASS TO PROTECT PERSONNEL FROM UNNECESSARY RADIATION EXPOSURE TO PROPEL GROWTH 75
TABLE 16 MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED GLASS, DOORS, AND WINDOWS, BY REGION, 2021–2028 (USD MILLION) 75
6.4 LEAD-LINED DRYWALLS & PLYWOOD 76
6.4.1 GROWING DEMAND FOR LEAD-LINED PLYWOOD FOR HEAVIER LEAD SHIELDING REQUIREMENTS TO BOOST MARKET 76
TABLE 17 MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED DRYWALLS & PLYWOOD, BY REGION, 2021–2028 (USD MILLION) 76
6.5 SHIELDS, BARRIERS, AND BOOTHS 77
6.5.1 INCREASING NUMBER OF DIAGNOSTIC IMAGING CENTERS TO DRIVE GROWTH 77
TABLE 18 MEDICAL RADIATION SHIELDING MARKET FOR SHIELDS, BARRIERS, AND BOOTHS, BY REGION, 2021–2028 (USD MILLION) 78
6.6 LEAD SHEETS 78
6.6.1 CORROSION RESISTANCE ASSOCIATED WITH LEAD SHEETS TO FUEL DEMAND 78
TABLE 19 MEDICAL RADIATION SHIELDING MARKET FOR LEAD SHEETS, BY REGION, 2021–2028 (USD MILLION) 79
6.7 LEAD BRICKS 79
6.7.1 RESISTANCE TO DAMAGE TO DRIVE ADOPTION OF LEAD BRICKS 79
TABLE 20 MEDICAL RADIATION SHIELDING MARKET FOR LEAD BRICKS, BY REGION, 2021–2028 (USD MILLION) 80
6.8 HIGH-DENSITY CONCRETE BLOCKS 80
6.8.1 SIGNIFICANT ATTENUATION PROVIDED BY HIGH-DENSITY CONCRETE BLOCKS TO BOOST DEMAND 80
TABLE 21 MEDICAL RADIATION SHIELDING MARKET FOR HIGH-DENSITY CONCRETE BLOCKS, BY REGION, 2021–2028 (USD MILLION) 81
6.9 X-RAY ROOMS 81
6.9.1 DEVELOPMENT OF NEW MATERIALS AS ALTERNATIVES TO LEAD TO CREATE GROWTH OPPORTUNITIES 81
TABLE 22 MEDICAL RADIATION SHIELDING MARKET FOR X-RAY ROOMS, BY REGION, 2021–2028 (USD MILLION) 82
6.10 LEAD CURTAINS & SCREENS 82
6.10.1 GREATER SHIELDING CAPABILITY OF THICK LEAD SCREENS TO FAVOR MARKET GROWTH 82
TABLE 23 MEDICAL RADIATION SHIELDING MARKET FOR LEAD CURTAINS & SCREENS, BY REGION, 2021–2028 (USD MILLION) 83
6.11 LEAD ACRYLIC 83
6.11.1 SUPERIOR VISUAL CLARITY AND HIGH LIGHT TRANSMISSION OF LEAD ACRYLIC TO FUEL ADOPTION 83
TABLE 24 MEDICAL RADIATION SHIELDING MARKET FOR LEAD ACRYLIC, BY REGION, 2021–2028 (USD MILLION) 84
7 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION 85
7.1 INTRODUCTION 86
TABLE 25 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 86
7.2 RADIATION THERAPY SHIELDING 86
TABLE 26 RADIATION THERAPY SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 27 RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 87
7.2.1 LINEAR ACCELERATORS 87
7.2.1.1 Growing adoption of linear accelerators to drive market growth 87
TABLE 28 MEDICAL RADIATION SHIELDING MARKET FOR LINEAR ACCELERATORS, BY REGION, 2021–2028 (USD MILLION) 88
7.2.2 MULTIMODALITY IMAGING 88
7.2.2.1 Recent advances in multimodality imaging to boost market 88
TABLE 29 MEDICAL RADIATION SHIELDING MARKET FOR MULTIMODALITY IMAGING, BY REGION, 2021–2028 (USD MILLION) 88
7.2.3 CYCLOTRONS 89
7.2.3.1 Ability of cyclotrons to produce high yields of short half-life, neutron-deficient radioisotopes to favor market growth 89
TABLE 30 MEDICAL RADIATION SHIELDING MARKET FOR CYCLOTRONS, BY REGION, 2021–2028 (USD MILLION) 90
7.2.4 BRACHYTHERAPY 90
7.2.4.1 Ability of brachytherapy to deliver low-dose radiation to drive market 90
TABLE 31 MEDICAL RADIATION SHIELDING MARKET FOR BRACHYTHERAPY, BY REGION, 2021–2028 (USD MILLION) 91
7.2.5 PROTON THERAPY 91
7.2.5.1 Non-invasive and non-threatening nature of proton therapy to fuel adoption 91
TABLE 32 MEDICAL RADIATION SHIELDING MARKET FOR PROTON THERAPY, BY REGION, 2021–2028 (USD MILLION) 92
7.3 DIAGNOSTIC SHIELDING 92
TABLE 33 DIAGNOSTIC SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION) 92
TABLE 34 DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
7.3.1 CT SCANNERS 93
7.3.1.1 Rising demand for CT systems from hospitals, clinics, and ASCs to drive market 93
TABLE 35 MEDICAL RADIATION SHIELDING MARKET FOR CT SCANNERS, BY REGION, 2021–2028 (USD MILLION) 94
7.3.2 X-RAY IMAGING 94
7.3.2.1 Consistent high quality of images provided by digital imaging to boost demand 94
TABLE 36 MEDICAL RADIATION SHIELDING MARKET FOR X-RAY IMAGING, BY REGION, 2021–2028 (USD MILLION) 95
7.3.3 MRI 95
7.3.3.1 Wide use of MRI in hospitals for medical diagnosis and staging of diseases to boost growth 95
TABLE 37 MEDICAL RADIATION SHIELDING MARKET FOR MRI, BY REGION, 2021–2028 (USD MILLION) 96
7.3.4 NUCLEAR IMAGING 96
7.3.4.1 Recent advances in nuclear medicine to increase number of nuclear medicine procedures globally 96
TABLE 38 MEDICAL RADIATION SHIELDING MARKET FOR NUCLEAR MEDICINE, BY REGION, 2021–2028 (USD MILLION) 97
8 MEDICAL RADIATION SHIELDING MARKET, BY END USER 98
8.1 INTRODUCTION 99
TABLE 39 MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 99
8.2 HOSPITALS, ASCS, AND CLINICS 99
8.2.1 INCREASING NUMBER OF INTERNAL RADIATION THERAPY PROCEDURES TO BOOST MARKET GROWTH 99
TABLE 40 MEDICAL RADIATION SHIELDING MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021–2028 (USD MILLION) 100
8.3 DIAGNOSTIC CENTERS 100
8.3.1 GROWING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE GROWTH 100
TABLE 41 MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION) 101
9 MEDICAL RADIATION SHIELDING MARKET, BY REGION 102
9.1 INTRODUCTION 103
TABLE 42 MEDICAL RADIATION SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION) 103
9.2 NORTH AMERICA 103
9.2.1 NORTH AMERICA: RECESSION IMPACT 103
FIGURE 24 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT 104
TABLE 43 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 44 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 105
TABLE 45 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 105
TABLE 46 NORTH AMERICA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 47 NORTH AMERICA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 48 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 106
9.2.2 US 107
9.2.2.1 US to dominate North American medical radiation shielding market during forecast period 107
TABLE 49 US: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 108
TABLE 50 US: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 108
TABLE 51 US: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 109
TABLE 52 US: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 109
TABLE 53 US: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 109
9.2.3 CANADA 110
9.2.3.1 Increasing number of radiography procedures to support market growth in Canada 110
TABLE 54 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 111
TABLE 55 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 111
TABLE 56 CANADA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 57 CANADA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 58 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 112
9.3 EUROPE 113
9.3.1 EUROPE: RECESSION IMPACT 113
TABLE 59 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 60 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 114
TABLE 61 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 115
TABLE 62 EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 63 EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 64 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.3.2 GERMANY 116
9.3.2.1 Growing geriatric population and increasing radiography procedures in Germany to favor market growth 116
TABLE 65 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 117
TABLE 66 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 117
TABLE 67 GERMANY: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 68 GERMANY: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 69 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 118
9.3.3 FRANCE 119
9.3.3.1 Large number of CT procedures performed to fuel market 119
TABLE 70 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 119
TABLE 71 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 120
TABLE 72 FRANCE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 73 FRANCE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 74 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 121
9.3.4 UK 121
9.3.4.1 Increasing government initiatives and support to aid market 121
TABLE 75 UK: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 122
TABLE 76 UK: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 122
TABLE 77 UK: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 78 UK: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 79 UK: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 123
9.3.5 REST OF EUROPE 124
TABLE 80 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 124
TABLE 81 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 124
TABLE 82 REST OF EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 83 REST OF EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 84 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 125
9.4 ASIA PACIFIC 126
9.4.1 ASIA PACIFIC: RECESSION IMPACT 126
FIGURE 25 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT 127
TABLE 85 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 86 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 128
TABLE 87 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 129
TABLE 88 ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 89 ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 90 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 130
9.4.2 CHINA 130
9.4.2.1 Large patient pool and rising healthcare spending to aid market 130
TABLE 91 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 131
TABLE 92 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 131
TABLE 93 CHINA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 94 CHINA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 95 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 132
9.4.3 JAPAN 133
9.4.3.1 Rising awareness about radiation exposure to drive market 133
TABLE 96 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 97 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 134
TABLE 98 JAPAN: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 99 JAPAN: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 100 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 135
9.4.4 INDIA 135
9.4.4.1 Favorable government policies and healthcare infrastructure to support market 135
TABLE 101 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 102 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 136
TABLE 103 INDIA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 104 INDIA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 105 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 137
9.4.5 REST OF ASIA PACIFIC 138
TABLE 106 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC, 2020 VS. 2040 138
TABLE 107 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 139
TABLE 108 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 139
TABLE 109 REST OF ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 110 REST OF ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 111 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 140
9.5 REST OF THE WORLD (ROW) 141
9.5.1 REST OF THE WORLD (ROW): RECESSION IMPACT 141
TABLE 112 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 142
TABLE 113 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION) 143
TABLE 114 REST OF THE WORLD: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 115 REST OF THE WORLD: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 116 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10 COMPETITIVE LANDSCAPE 145
10.1 OVERVIEW 145
TABLE 117 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL RADIATION SHIELDING MARKET 145
10.2 MARKET RANKING 146
TABLE 118 TOP 3 COMPANIES IN MEDICAL RADIATION SHIELDING MARKET 146
10.3 COMPANY EVALUATION QUADRANT FOR TOP PLAYERS 146
10.3.1 STARS 147
10.3.2 EMERGING LEADERS 147
10.3.3 PARTICIPANTS 147
10.3.4 PERVASIVE PLAYERS 147
FIGURE 26 MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022 148
10.4 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS 149
10.4.1 PROGRESSIVE COMPANIES 149
10.4.2 STARTING BLOCKS 149
10.4.3 RESPONSIVE COMPANIES 149
10.4.4 DYNAMIC COMPANIES 149
FIGURE 27 MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022 150
10.5 COMPETITIVE BENCHMARKING 151
TABLE 119 MEDICAL RADIATION SHIELDING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 151
10.6 COMPANY FOOTPRINT ANALYSIS 151
TABLE 120 FOOTPRINT ANALYSIS OF COMPANIES 151
TABLE 121 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES 152
TABLE 122 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES 153
10.7 COMPETITIVE SCENARIO 154
10.7.1 DEALS 154
TABLE 123 KEY DEALS, JANUARY 2020–MAY 2023 154
10.7.2 OTHER DEVELOPMENTS 155
TABLE 124 OTHER KEY DEVELOPMENTS, JANUARY 2020–MAY 2023 155
11 COMPANY PROFILES 156
11.1 KEY PLAYERS 156
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY) 156
TABLE 125 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): BUSINESS OVERVIEW 156
FIGURE 28 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): COMPANY SNAPSHOT (2022) 157
11.1.2 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.) 161
TABLE 126 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): BUSINESS OVERVIEW 161
FIGURE 29 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): COMPANY SNAPSHOT (2022) 162
11.1.3 NELCO WORLDWIDE 165
TABLE 127 NELCO WORLDWIDE: BUSINESS OVERVIEW 165
11.1.4 GAVEN INDUSTRIES, INC. 167
TABLE 128 GAVEN INDUSTRIES, INC.: BUSINESS OVERVIEW 167
11.1.5 RADIATION PROTECTION PRODUCTS, INC. 168
TABLE 129 RADIATION PROTECTION PRODUCTS, INC.: BUSINESS OVERVIEW 168
11.1.6 MARSHIELD (A DIVISION OF MARS METAL CO.) 170
TABLE 130 MARSHIELD (A DIVISION OF MARS METAL CO.): BUSINESS OVERVIEW 170
11.1.7 RAY-BAR ENGINEERING CORP. 172
TABLE 131 RAY-BAR ENGINEERING CORP.: BUSINESS OVERVIEW 172
11.1.8 AMRAY MEDICAL 174
TABLE 132 AMRAY MEDICAL: BUSINESS OVERVIEW 174
11.1.9 A&L SHIELDING 175
TABLE 133 A&L SHIELDING: BUSINESS OVERVIEW 175
11.1.10 GLOBAL PARTNERS IN SHIELDING, INC. 177
TABLE 134 GLOBAL PARTNERS IN SHIELDING, INC.: BUSINESS OVERVIEW 177
11.1.11 VERITAS MEDICAL SOLUTIONS LLC 178
TABLE 135 VERITAS MEDICAL SOLUTIONS, LLC: BUSINESS OVERVIEW 178
11.1.12 ALIMED, INC. 179
TABLE 136 ALIMED, INC.: BUSINESS OVERVIEW 179
11.1.13 PROTECH MEDICAL 180
TABLE 137 PROTECH MEDICAL: BUSINESS OVERVIEW 180
11.1.14 GLOBE COMPOSITE SOLUTIONS LLC 181
TABLE 138 GLOBE COMPOSITE SOLUTIONS LLC: BUSINESS OVERVIEW 181
11.1.15 ULTRARAY 182
TABLE 139 ULTRARAY: BUSINESS OVERVIEW 182
11.1.16 MARS METAL COMPANY 183
TABLE 140 MARS METAL COMPANY: BUSINESS OVERVIEW 183
11.1.17 NUCLEAR LEAD CO. 185
TABLE 141 NUCLEAR LEAD CO.: BUSINESS OVERVIEW 185
11.1.18 NUCLEAR SHIELDS B.V. 186
TABLE 142 NUCLEAR SHIELDS B.V.: BUSINESS OVERVIEW 186
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 188
11.2.1 SHIELDING INTERNATIONAL INC. 188
11.2.2 BAR-RAY PRODUCTS, INC. 188
11.2.3 XENA SHIELD 189
11.2.4 BURLINGTON MEDICAL 190
11.2.5 SIMAD SRL 190
11.2.6 EUROPEAN EMC PRODUCTS 191
12 APPENDIX 192
12.1 DISCUSSION GUIDE 192
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 197
12.3 CUSTOMIZATION OPTIONS 199
12.4 RELATED REPORTS 199
12.5 AUTHOR DETAILS 200